Inflammation plays a crucial role in the development and progression of atherosclerotic plaques. The aim of this study is to compare culture supernatants from uncomplicated and complicated carotid atherosclerotic plaques by a multiplex approach, to assess the molecular mediators associated with a complicated plaque phenotype. Atherosclerotic plaques were obtained from 17 patients undergoing carotid endarterectomy. Supernatants from plaque cultures were evaluated by Bio-Plex cytokine assay to determine 27 pro- and anti-inflammatory cytokines, chemokines and growth factors. Complicated plaques secreted higher levels of IP-10 (p = 0.027) and lower levels of IL-5 (p = 0.045) than did uncomplicated ones. Distinctive secretory patterns of cytokines, chemokines and growth factors were present in the two types of plaque. Our study identifies IP-10 and IL-5 as proteins differentiating complicated and uncomplicated plaques from human carotid arteries and provides new insights into the interplay of molecular mediators with atherosclerotic plaque progression.
VinkASchoneveldAHRichardWde KleijnDPFalkEBorstCPasterkampG. Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors?J Am Coll Cardiol2001; 38:718–23.
2.
RobertsonAKHanssonGK. T cells in atherogenesis. For better or for worse?Arterioscler Thromb Vasc Biol2006; 26:2421–32.
3.
DahlTBYndestadASkjellandM. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation2007; 115:972–80.
4.
FrostegardJUlfgrenAKNybergPHedinUSwedenborgJAnderssonUHanssonGK. Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis1999; 145:33–43.
5.
TedguiAMallatZ. Anti-inflammatory mechanisms in the vascular wall. Circ Res2001; 88:877–87.
6.
TedguiAMallatZ. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev2006; 86:515–81.
7.
RidkerPMRifaiNPfefferMSacksFLepageSBraunwaldE. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation2000; 101:2149–53.
8.
HeeschenCDimmelerSHammCWFichtlschererSBoersmaESimoonsMLZeiherAM; CAPTURE Study Investigators. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation2003; 107:2109–14.
9.
TziakasDNChalikiasGKKaskiJCKekesAHatzinikolaouEIStakosDATentesIKKortsarisAXHatserasDI. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis2007; 193:196–203.
10.
LorenzoOMartín-VenturaJLBlanco-ColioLMEgidoJTuñónJ. The proteomic approach in the development of prognostic biomarkers in atherothrombosis. Recent Pat Cardiovasc Drug Discov2009; 4:25–30.
11.
Alvarez-LlamasGde la CuestaFBarderasMEDardeVPadialLRVivancoF. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics2008; 5:679–91.
12.
PenduRTerraubeVChristopheODGahmbergCGde GrootPGLentingPJDenisCV. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood2006; 108:3746–52.
13.
TakatsuKKouroTNagaiY. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol2009; 101:191–236.
14.
ChengCTempelDvan HaperenR. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest2007; 117:616–26.
15.
TaubDDLongoDLMurphyWJ. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood1996; 87:1423–31.
16.
LibbyPSchoenbeckUMachFSelwynAPGanzP. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med1998; 104:14S–8S.
17.
GoriAMCesariFMarcucciRGiustiBPanicciaRAntonucciEGensiniGFAbbateR. The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis2009; 202:255–62.
18.
SchönbeckUSukhovaGKGerdesNLibbyP. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol2002; 161:499–506.
19.
SämpiMUkkolaOPäivänsaloMKesäniemiYABinderCJHörkköS. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol2008; 52:1370–8.
20.
BinderCJHartvigsenKChangMKMillerMBroideDPalinskiWCurtissLKCorrMWitztumJL. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest2004; 114:427–37.
21.
HorkkoSBirdDAMillerE. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest1999; 103:117–28.
22.
LinJLiMWangZHeSMaXLiD. The role of CD4+CD25+ regulatory T cells in macrophagederived foam-cell formation. J Lipid Res2010; 51:1208–17.
23.
GeorgeJ. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nat Clin Pract Cardiovasc Med2008; 5:531–40.
24.
EikelenboomMJKillesteinJKragtJJUitdehaagBMJPolmanCH. Gender differences in multiple sclerosis: Cytokines and vitamin D. J Neurol Sci2009; 286:40–2.
25.
GoetzlEJHuangMCKonJ. Gender specificity of altered human immune cytokine profiles in aging. FASEB J2010; 24:3580–9.
26.
Martin-VenturaJLDuranMCBlanco-ColioLM. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation2004; 110:2216–9.
27.
LepeddaAJCiglianoACherchiGM. A proteomic approach to differenziate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis2009; 203:112–8.
28.
DonnersMMVerluytenMJBouwmanFG. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol2005; 206:39–45.
